Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

December 15, 2015 02:00 ET | Source: Camurus AB

Camurus och Braeburn Pharmaceuticals inleder fas 3-studie av långtidsverkande behandling för opiatberoende

Lund, Sverige och Princeton, New Jersey, USA — 15 december 2015 — Camurus och Braeburn Pharmaceuticals meddelar idag att första patienten har doserats i en klinisk fas 3-studie av CAM2038 för...
December 15, 2015 02:00 ET | Source: Camurus AB

Braeburn Pharmaceuticals and Camurus announces start of Phase 3 trial of long-acting buprenorphine treatments for opioid dependence

Princeton, New Jersey and Lund, Sweden — 15 December 2015 — Braeburn Pharmaceuticals and Camurus today announced that the first patient has been enrolled in a Phase 3 clinical trial of CAM2038,...
December 14, 2015 02:00 ET | Source: Camurus AB

Camurus utser Chief Commercial Officer

Lund, Sverige – 14 december 2015 — Camurus (NASDAQ STO: CAMX) meddelar idag att man utsett Richard Jameson till bolagets Chief Commercial Officer och medlem av bolagets ledningsgrupp, därigenom...
December 14, 2015 02:00 ET | Source: Camurus AB

Camurus appoints Chief Commercial Officer

Lund, Sweden – 14 December 2015 — Camurus (NASDAQ STO: CAMX) today announces the appointment of Richard Jameson to the position of Chief Commercial Officer and member of the Executive Management Team,...